FundedIQ
Biotechnology

Jellagen: Funding, Investors & Team (Sep 2026)

Our jellyfish collagen-based innovation addresses complex regenerative medical needs, shaping next generation treatments and supporting current and future scientific research. At the heart of our products is marine-sourced Collagen Type 0, an evolutionary ancient stem collagen that is foundational, allowing greater applications across multiple indications.

www.jellagen.co.uk LinkedIn Pembroke Dock, United Kingdom 11-50 employees
Biotechnology Health Care Life Science Medical Medical grade collagen Native collagen Cell culture reagents Wound healing
Total raised
$10.6M
Rounds
2
Latest
Undisclosed round
Feb 2026

Jellagen has raised $10.6M across 2 funding rounds on record, the most recent an undisclosed round announced in Feb 2026.

Jellagen Company Profile and Key Stats

Total funding raised
$10.6M
across 2 rounds on record
Funding rounds on record
2
1 with no disclosed amount
Latest funding round
Undisclosed round
Feb 2026
Employees
11-50
reported band
Headquarters
Pembroke Dock, United Kingdom

Latest funding round on record: Feb 2026.

Jellagen Funding Rounds

Date
Round
Amount
Undisclosed round
Undisclosed
Series A
$10.6M

1 of 2 rounds was announced without a disclosed amount and is excluded from the total.

Jellagen raised $10.6M in a Series A announced in Dec 2022.

3.2 years later, an undisclosed round was announced in Feb 2026 with no disclosed amount.

Jellagen Founders and Leadership Team

Name
Role
Contact
Andrew Spragg
Founder
Andrew Mearns Spragg
CEO
Locked

Contact details for the Jellagen team: 1 of 2 have an email address on file.

Start 14-day free trial →

Jellagen Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
5,273
$4.0M

Funded Startups Like Jellagen in Biotechnology and Pembroke Dock

Companies Similar to Jellagen

Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…

Series A $33.6M

Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…

Undisclosed round $3.5M

Concert Bio helps businesses create optimal microbial communities.

Undisclosed round $130k

RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…

Series A $113M

N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…

Undisclosed round $3.6M

Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…

Undisclosed round $3.0M

Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.

Series A $32.5M

IMU is a discovery engine mapping the immune system to advance precision medicine.

Series A $38.4M

Mykor is a climate tech start-up. It decarbonizes the construction industry by manufacturing carbon-negative…

Undisclosed round $5.4M

Neurovalens provides cutting-edge solutions in the realms of neuroscience, bioscience, and neurophysiology.…

Undisclosed round

Voxmind's biometric confirmation and authentication platform that provides voice based biometrics that helps…

Pre-Seed $740k

Five is a biometric payment services company that offers thumb recognition technology for safe transactions.

Seed $6.0M

Jellagen Funding FAQs

What does Jellagen do?

Our jellyfish collagen-based innovation addresses complex regenerative medical needs, shaping next generation treatments and supporting current and future scientific research. At the heart of our products is marine-sourced Collagen Type 0, an evolutionary ancient stem collagen that is foundational, allowing greater applications across multiple indications.

How much funding has Jellagen raised?

Jellagen has raised $10.6M across 2 rounds on record.

When did Jellagen last raise funding?

Jellagen's most recent funding round on record was announced in Feb 2026. The amount was not disclosed.

Who founded Jellagen?

FundedIQ lists Andrew Spragg (Founder) at Jellagen.

Who is the CEO of Jellagen?

Andrew Mearns Spragg is listed as CEO at Jellagen.

Where is Jellagen headquartered?

Jellagen is based in Pembroke Dock, Pembrokeshire, United Kingdom.

How many employees does Jellagen have?

Jellagen is in the 11-50 employee band.

About FundedIQ's Jellagen Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Jellagen is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.